SANUWAVE Health Inc (OTCPK:SNWV)

$ 22.9 -0.1 (-0.43%) Market Cap: 195.43 Mil Enterprise Value: 225.84 Mil PE Ratio: 3.41 PB Ratio: 0 GF Score: 44/100

Q3 2024 SANUWAVE Health Inc Earnings Call Transcript
Nov 08, 2024

$22.2 (+14.43%)

Earnings
Q2 2024 SANUWAVE Health Inc Earnings Call Transcript
Aug 13, 2024

$6 (+3.90%)

Earnings
Q1 2024 SANUWAVE Health Inc Earnings Call Transcript
May 10, 2024

$8.59 (+4.09%)

Earnings
Q4 2023 SANUWAVE Health Inc Earnings Call Transcript
Mar 22, 2024

$7.41 (-1.25%)

Earnings
SANUWAVE Health Inc Business Update- Conference Call Transcript
Nov 15, 2022
SANUWAVE Health Inc at MicroCap Rodeo -- Windy City Roundup Transcript
Oct 13, 2022
SANUWAVE Health Inc at Emerging Growth Conference Transcript
Mar 02, 2022
SANUWAVE Health Inc at LD Micro Main Event Transcript
Dec 14, 2020
Q1 2020 SANUWAVE Health Inc Earnings Call Transcript
May 18, 2020

$107.44 (+10.40%)

Earnings
Q4 2019 SANUWAVE Health Inc Earnings Call Transcript
Mar 31, 2020

$75 (-6.98%)

Earnings
Medical device breakthrough 2020 Transcript
Mar 03, 2020
11 Minutes with Shri video blog, vol. 1: Dr. Armstrong Transcript
Jun 26, 2019

SANUWAVE Health Inc at LD Micro Main Event Transcript

Dec 14, 2020 / 03:00PM GMT

Release Date Price: $65.16 (-0.66%)

Transcript

Operator

All right, everyone. Welcome this morning. I am with Kevin Richardson, all right. And he is with SANUWAVE Health. They are a medical technology company focused on the development and commercialization of its proprietary FDA-cleared system for use in regenerative medicine and wound care. In August 2020, the company acquired Celularity, Inc.'s UltraMIST, ultrasound therapy device and partnership rights for Wound Care Biologic products.

Take it away, Kevin.

Kevin Richardson

SANUWAVE Health, Inc. - CEO & Chairman of the Board of Directors

Okay. Thank you very much. My name is Kevin Richardson. I'm the CEO and Chairman of SANUWAVE Health. We're a Wound Care Solutions company. I'll be spending the next 10 minutes talking about our portfolio, our go-to-market strategy and why we represent an interesting investment opportunity in ways that we can help heal today and cure tomorrow.

Let me first start with the forward-looking statement. Please review this, if you have time. It is obligatory that we have to say. Great.

So the company

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.